02547nam a2200409 i 45000010008000000030008000080050017000160060019000330070007000520080041000590200033001000350017001330390012001500400036001620500023001980900025002211000026002462450086002722640037003582640011003953000023004063360021004293370023004503380032004734900044005055040051005495050513006005060060011135200569011735960007017426500021017498300057017708560110018279490014019379260105019517580081020566786195FlBoTFG20150115163112.0m|||||o||d||||||||cr||||150115t20152015fluad   ob    001 0 eng d  a9781466561502 (e-book : PDF)  aocn895661613  aexclude  aFlBoTFGbengerdacFlBoTFGdAEU 4aR853.C55bN48 2015  aInternet AccessbAEU1 aNg, Tie-Hua,eauthor.10aNoninferiority testing in clinical trials :bissues and challenges /cTie-Hua Ng. 1aBoca Raton :bCRC Press,c[2015] 4cÂ©2015  a1 online resource.  atext2rdacontent  acomputer2rdamedia  aonline resource2rdacarrier1 aChapman & Hall/CRC biostatistics series  aIncludes bibliographical references and index.0 aIntroduction -- Choice of noninferiority margin for the mean difference -- Choice of noninferiority margin for the mean ratio and hazard ratio -- Noninferiority Hypotheses with Binary Endpoints -- Two statistical approaches for testing the noninferiority hypothesis -- Switching between superiority and noninferiority -- Multiple historical studies and meta-analysis -- Three treatment groups -- Regulatory guidances -- Intention-to-treat versus per-protocol -- Thrombolytic example -- Issues and challenges.  aAccess restricted to authorized users and institutions.  a"This book focuses on the rationale of choosing the noninferiority (NI) margin as a small fraction of the therapeutic effect of the active control in a clinical trial. It discusses issues of estimating the effect size based on historical placebo control trials of the active control. The book also covers basic concepts related to NI trials, such as essay sensitivity, constancy assumption, discounting, and preservation. Other topics described include patient populations, three-arm trials, and testing equivalence of three or more groups"--Provided by publisher.  a44 0aClinical trials. 0aChapman & Hall/CRC biostatistics series (Unnumbered)403University of Alberta Accessuhttp://marc.crcnetbase.com/isbn/9781466561502z(Unlimited Concurrent Users)  hUAINzCRC  aInternet AccesswLCc1i6786195-1001lINTERNETmUAINTERNETrYsYtE-RESOURCEu1/20/2015xE-BOOKzCRC01ahttp://id.loc.gov/authorities/names/n85241294bhttp://viaf.org/viaf/16214363